Aliases for FLT4 Gene
- Fms Related Receptor Tyrosine Kinase 4 2 3 5
- Vascular Endothelial Growth Factor Receptor 3 2 3 4
- VEGFR-3 2 3 4
- VEGFR3 2 3 4
- Feline McDonough Sarcoma (FMS)-Like Tyrosine Kinase 4 2 3
- Tyrosine-Protein Kinase Receptor FLT4 3 4
- Primary Congenital Lymphedema 2 3
- Fms Related Tyrosine Kinase 4 2 3
- Fms-Like Tyrosine Kinase 4 3 4
- VEGF Receptor-3 2 3
External Ids for FLT4 Gene
Previous GeneCards Identifiers for FLT4 Gene
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
GeneCards Summary for FLT4 Gene
FLT4 (Fms Related Receptor Tyrosine Kinase 4) is a Protein Coding gene. Diseases associated with FLT4 include Lymphatic Malformation 1 and Congenital Heart Defects, Multiple Types, 7. Among its related pathways are Nanog in Mammalian ESC Pluripotency and Ras signaling pathway. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is KDR.
UniProtKB/Swiss-Prot Summary for FLT4 Gene
Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr-185', and of AKT1 at 'Ser-473'.
Vascular endothelial growth factor is a signaling protein involved in the regulation of angiogenesis and vasculogenesis. VEGF binds to and activates a receptor tyrosine kinase, VEGFR, through transphosphorylation. Three VEGFR isoforms have been identified in humans.